/CNW/ -- Equity Insider News Commentary – Despite alarming federal budget cuts that stand to potentially harm the national battle against cancer, it appears...
Equity Insider News Commentary
/CNW/ -- USA News Group News Commentary – Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is...
USA News Group News Commentary
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – In the United States, federal budget cuts threaten to slow the nation’s progress in the fight against...
Announced the voting results from its Annual General Meeting of Shareholders held on Friday, August ...
/CNW/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"), a clinical-stage immunotherapy company...
SAN DIEGO , Aug. 11, 2025 /PRNewswire/ -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"), a clinical-stage immunotherapy...
Today reported financial results and recent highlights for the second quarter of 2025. "We have turned ...
Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members...